RetaMaps

Urgent Care Plus and Wellness

Urgent Care Plus and Wellness · 20711 Bellaire Boulevard · Richmond, TX 77407

4.9· 270 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss
  • Endocrine / metabolic care

About this practice

Urgent Care Plus & Wellness is a walk-in urgent care and wellness clinic in Richmond, Texas, serving Katy, Aliana, Sugar Land and the wider West Houston area, according to its website. The site says it was founded by Dr. Luke Afuwape, MD, a board-certified emergency medicine physician, and describes pediatric urgent care, injury treatment, immigration medical exams, hormone optimization and mental health support. Weight-loss care, endocrine care and IV therapy are also listed. Google shows a 4.9-star rating across 270 reviews since 2024, with 51 in the past year, and reviewers most often mention the staff and the providers' knowledge.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.9
Google rating · 270 reviews
51
reviews in the past year (avg ★ 4.8)

Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-26. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.9 across 270 Google reviews. Of the 100 reviews we analyzed, 96 (96%) are positive (4–5★) and 4 (4%) are negative (1–2★).

What patients like

  • Friendly, helpful staff32 reviews
  • Knowledgeable, professional providers25 reviews
  • Feeling listened to17 reviews
  • Clean, comfortable office7 reviews

Common complaints

  • Staff or front-desk issues2 of 4 negative
  • Billing, pricing or insurance problems2 of 4 negative
5★
95
4★
1
3★
0
2★
0
1★
4

Most recent Google reviews

ax r.★★★★★2026-09-26

Great people and staff to work with

Cruz K.★★★★★2026-09-26

Very professional & and smooth

Timaat c.★★★★★2026-09-21

I had a great experience at this urgent care. Everyone who works there is very nice, accommodating, and attentive. They genuinely take the time to listen and make sure you feel comfortable and cared for. A special thank you to Dr. Cassandra, who was very friendly, caring, and easy to talk to. She made me feel comfortable and took the time to help me understand everything. I really appreciate the excellent care I received, and I will definitely come back again. Highly recommend!

Christina U.★★★★★2026-09-19

Cassandra and Lena were professional and attentive. Happen to stop here for a Myers iv therapy. Lena did fantastic at the insertion. I literally felt NOTHING! Casandra explained all precautions and thoroughly went over my vitals and history. I left here feeling like they really cared for my well being. Keep these ladies at this locations at all cost! I’ll be back. Oh and Wednesday they have 30% off IVs! What a deal!

Jessica P.★★★★★2026-09-19

This place is great we were treated with respect and courtesy thanks

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Richmond

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs